219 related articles for article (PubMed ID: 32483624)
1. Yap1-Scribble polarization is required for hematopoietic stem cell division and fate.
Althoff MJ; Nayak RC; Hegde S; Wellendorf AM; Bohan B; Filippi MD; Xin M; Lu QR; Geiger H; Zheng Y; Diaz-Meco MT; Moscat J; Cancelas JA
Blood; 2020 Oct; 136(16):1824-1836. PubMed ID: 32483624
[TBL] [Abstract][Full Text] [Related]
2. CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling.
Zhang Z; Zhang F; Davis AK; Xin M; Walz G; Tian W; Zheng Y
Cell Rep; 2022 Jan; 38(2):110009. PubMed ID: 35021092
[TBL] [Abstract][Full Text] [Related]
3. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
[TBL] [Abstract][Full Text] [Related]
4. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
[TBL] [Abstract][Full Text] [Related]
5. YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.
He C; Lv X; Huang C; Hua G; Ma B; Chen X; Angeletti PC; Dong J; Zhou J; Wang Z; Rueda BR; Davis JS; Wang C
EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30755404
[TBL] [Abstract][Full Text] [Related]
6. Differential influence of YAP1 and TAZ on differentiation of intestinal epithelial cell: A review.
Fallah S; Beaulieu JF
Anat Rec (Hoboken); 2023 May; 306(5):1054-1061. PubMed ID: 35648375
[TBL] [Abstract][Full Text] [Related]
7. The cell fate determinant Scribble is required for maintenance of hematopoietic stem cell function.
Mohr J; Dash BP; Schnoeder TM; Wolleschak D; Herzog C; Tubio Santamaria N; Weinert S; Godavarthy S; Zanetti C; Naumann M; Hartleben B; Huber TB; Krause DS; Kähne T; Bullinger L; Heidel FH
Leukemia; 2018 May; 32(5):1211-1221. PubMed ID: 29467485
[TBL] [Abstract][Full Text] [Related]
8. The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation.
Fallah S; Beaulieu JF
Cells; 2020 Aug; 9(8):. PubMed ID: 32823612
[TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation.
Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S
Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260
[TBL] [Abstract][Full Text] [Related]
10. The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.
Mizukawa B; O'Brien E; Moreira DC; Wunderlich M; Hochstetler CL; Duan X; Liu W; Orr E; Grimes HL; Mulloy JC; Zheng Y
Blood; 2017 Sep; 130(11):1336-1346. PubMed ID: 28778865
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.
Nakatani K; Maehama T; Nishio M; Otani J; Yamaguchi K; Fukumoto M; Hikasa H; Hagiwara S; Nishina H; Mak TW; Honma T; Kondoh Y; Osada H; Yoshida M; Suzuki A
Cancer Sci; 2021 Oct; 112(10):4303-4316. PubMed ID: 34289205
[TBL] [Abstract][Full Text] [Related]
12. YAP1/TAZ drives ependymoma-like tumour formation in mice.
Eder N; Roncaroli F; Domart MC; Horswell S; Andreiuolo F; Flynn HR; Lopes AT; Claxton S; Kilday JP; Collinson L; Mao JH; Pietsch T; Thompson B; Snijders AP; Ultanir SK
Nat Commun; 2020 May; 11(1):2380. PubMed ID: 32404936
[TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.
Sakabe M; Fan J; Odaka Y; Liu N; Hassan A; Duan X; Stump P; Byerly L; Donaldson M; Hao J; Fruttiger M; Lu QR; Zheng Y; Lang RA; Xin M
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10918-10923. PubMed ID: 28973878
[TBL] [Abstract][Full Text] [Related]
14. Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1.
Jansson L; Larsson J
PLoS One; 2012; 7(2):e32013. PubMed ID: 22363786
[TBL] [Abstract][Full Text] [Related]
15. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
16. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.
Bora-Singhal N; Nguyen J; Schaal C; Perumal D; Singh S; Coppola D; Chellappan S
Stem Cells; 2015 Jun; 33(6):1705-18. PubMed ID: 25754111
[TBL] [Abstract][Full Text] [Related]
17. Integrin-FAK-CDC42-PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells.
Hicks-Berthet J; Varelas X
Bioessays; 2017 Oct; 39(10):. PubMed ID: 28891248
[TBL] [Abstract][Full Text] [Related]
18. LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance.
Lee SU; Maeda M; Ishikawa Y; Li SM; Wilson A; Jubb AM; Sakurai N; Weng L; Fiorini E; Radtke F; Yan M; Macdonald HR; Chen CC; Maeda T
Blood; 2013 Feb; 121(6):918-29. PubMed ID: 23134786
[TBL] [Abstract][Full Text] [Related]
19. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
[TBL] [Abstract][Full Text] [Related]
20. Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation.
Sengupta A; Duran A; Ishikawa E; Florian MC; Dunn SK; Ficker AM; Leitges M; Geiger H; Diaz-Meco M; Moscat J; Cancelas JA
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9957-62. PubMed ID: 21653884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
